This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Novartis Ag, University of Pennsylvania. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021-2024
Title: Lan Cao: Innovator in Paramagnetic Particle Technology
Introduction
Lan Cao is a prominent inventor based in East Hanover, NJ (US). She has made significant contributions to the field of cell separation technology, holding 2 patents that focus on innovative methods for handling paramagnetic particles in cell suspensions. Her work has implications for various applications in biomedical research and clinical settings.
Latest Patents
Cao's latest patents include systems and methods for flow-through separation of paramagnetic particle-bound cells in a cell suspension containing both bound and unbound cells. These patents also detail methods for removing paramagnetic particles from these cells. Additionally, her inventions encompass a flow-through magnetic separation/debeading module and a flow-through spinning membrane debeading module, which enhance the efficiency of cell separation processes.
Career Highlights
Throughout her career, Lan Cao has worked with notable organizations such as Novartis and the University of Pennsylvania. Her experience in these institutions has allowed her to develop and refine her innovative technologies, contributing to advancements in the field of cell biology.
Collaborations
Cao has collaborated with esteemed colleagues, including Fabio Fachin and Rodney Rietze. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing her research and development efforts.
Conclusion
Lan Cao's contributions to paramagnetic particle technology exemplify her dedication to innovation in the field of cell separation. Her patents and collaborations reflect her commitment to advancing scientific knowledge and improving methodologies in biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile